Search

Your search keyword '"Pepic, A."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Pepic, A." Remove constraint Author: "Pepic, A." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
49 results on '"Pepic, A."'

Search Results

5. Stepped, evidence-based and integrated care service model vs. usual care for mental disorders: A randomized controlled trial (RECOVER)

6. Cardiac index-guided therapy to maintain optimised postinduction cardiac index in high-risk patients having major open abdominal surgery: the multicentre randomised iPEGASUS trial

10. A Mixed Method Evaluation of a Culturally Grounded After-School Arts Intervention on Native Youth

14. Longer Preoperative Antibiotic Duration Prior to High-Risk Ureteroscopy Does Not Decrease Infectious Complications.

15. Territorial Distribution Requirements Without Centripetal Pitfalls: Electoral Design for Power-Sharing Collective Presidencies.

16. MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes

18. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

23. Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke.

24. Resource Deployment in Response to Trauma Patients

27. Child Neurology:Bartonella henselaeNeuroretinitis in 2 Patients

28. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

32. Implementation of Encryption and Data Hiding in E-Health Application

34. Evaluating the Impact of a Culturally Sensitive Art Program on the Resilience, Perceived Stress, and Mood of Urban American Indian Youth

35. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

38. MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes

39. Types and Frequency of Errors in the Pre-Analytical Phase in the Clinical Laboratory - Single Center Study from Bosnia and Herzegovina

40. Additional file 1 of MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes

41. Streamlining a tangled web: Towards a truly democratic Bosnia and Herzegovina

42. Genetically Homogeneous or Heterogeneous Population –Distribution of the Recessive Allele in Selected Qualitative Characteristics of Selected Working-Age Population Sample

44. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

45. Contributors

47. EVALUATING THE IMPACT OF A CULTURALLY SENSITIVE ART PROGRAM ON THE RESILIENCE, PERCEIVED STRESS, AND MOOD OF URBAN AMERICAN INDIAN YOUTH.

48. ENSEMBLE MACHINE LEARNING METHODS TO PREDICT THE BALANCING OF AYURVEDIC CONSTITUENTS IN THE HUMAN BODY.

49. Child Neurology: Bartonella henselaeNeuroretinitis in 2 Patients

Catalog

Books, media, physical & digital resources